Tiliquinol (NSC-130828) is a non-systemic, luminal anti-amoebic compound frequently studied alongside tibroquinol. Its primary research application is in investigating amebic infections, including the experimental study of amebic liver abscess models in vivo and anti-parasitic activity in vitro.